Review

Acute Sinusitis

Authors: Brent Feldt, MD, Gregory R. Dion, MD, Erik K. Weitzel, MD, Kevin C. McMains, MD

Abstract

Sinusitis is a common patient complaint that carries with it a large economic burden. It is one of the most common reasons patients visit their primary care physician. Acute bacterial rhinosinusitis (ABRS) can be distinguished from other forms of rhinosinusitis based on symptom duration of <4 weeks in a patient with purulent rhinorrhea associated with facial pain or pressure. Native upper aerodigestive tract bacteria are the most common etiologic agents. Treatment of ABRS is targeted primarily at symptom improvement. Amoxicillin can be used based on the clinical scenario and patient comorbidities. Computed tomographic scans are reserved for complicated presentations or when there is concern for intracranial extension or other complications. A systematic approach to ABRS will allow for improved patient quality of life and a decreased overall economic burden of this common entity.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Shappert SM, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2007. Vital Health Stat 13. 2011; 169: 1–38.
 
2. Ray NF, Baraniuk JN, Thamer M, et al. Healthcare expenditures for sinusitis in 1996: contributions of asthma, rhinitis, and other airway disorders. J All Clin Immunol. 1999; 103: 408–414.
 
3. Bhattacharyya N. Contemporary assessment of the disease burden of sinusitis. Am J Rhinol Allergy. 2009; 23392–23395.
 
4. Lanza DC, Kennedy DW. Adult rhinosinusitis defined. Otolaryngol Head Neck Surg. 1997; 117: S1–S7.
 
5. Berg O, Carenfelt C, Rystedt G, et al. Occurrence of asymptomatic sinusitis in common cold and other acute ENT infections. Rhinology. 1986; 24: 223–225.
 
6. Rosenfeld RM, Singer M, Jones S. Systematic review of antimicrobials for patients with acute rhinosinusitis. Otolaryngol Head Neck Surg. 2007; 137: S32–S45.
 
7. Gwaltney JM Jr, Scheld WM, Sande MA, et al. The microbial etiology and antimicrobial therapy of adults with acute community-acquired sinusitis: a fifteen-year experience at the University of Virginia and review of other selected studies. J Allergy Clin Immunol. 1992; 90: 457–461.
 
8. Berger G, Berger RL. The contribution of flexible endoscopy for diagnosis of acute bacterial rhinosinusitis. Eur Arch Otorhinolaryngol. 2011; 268: 235–240.
 
9. Turner BW, Cail WS, Hendley JO, et al. Physiologic abnormalities in the paranasal sinuses during experimental rhinovirus colds. J Allergy Clin Immunol. 1992; 90: 474–478.
 
10. Younis RT, Anand VK, Davidson B. The role of computed tomography and magnetic resonance imaging in patients with sinusitis with complications. Laryngoscope. 2002; 112: 224–229.
 
11. Zinreich SJ. Rhinosinusitis: radiologic diagnosis. Otolaryngol Head Neck Surg. 1997; 117: S27–S34.
 
12. Lau J, Zucker D, Engels EA, et al. Diagnosis and Treatment of Acute Bacterial Rhinosinusitis. Evidence Report/Technology Assessment No. 9. Publication no. 99-E016. Rockville, MD: Agency for Health Care Policy and Research; 1999; .
 
13. Anon JB, Jacobs MR, Poole MD, et al. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg. 2004; 130: 1–45.
 
14. Berrettini S, Carabelli A, Sellari-Franceschini S, et al. Perennial allergic rhinitis and chronic sinusitis: correlation with rhinologic risk factors. Allergy. 1999; 54: 242–248.
 
15. Newman LJ, Platts-Mills TA, Phillips CD, et al. Chronic sinusitis. Relationship of computed tomographic findings to allergy, asthma, and eosinophilia. JAMA. 1994; 271: 363–367.
 
16. Ferguson BJ, Mabry RL. Laboratory diagnosis. Otolaryngol Head Neck Surg. 1997; 117: S12–S26.
 
17. Chow AW, Benninger MS, Brook I, et al. IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis. 2012; 54:; 1041–1045.
 
18. Slavin RG, Spector SL, Bernstein IL, et al. The diagnosis and management of sinusitis: a practice parameter update. J Allergy Clin Immunol. 2005; 116: S13–S47.
 
19. Lieu JE, Feinstein AR. Confirmations and surprises in the association of tobacco use with sinusitis. Arch Otolaryngol Head Neck Surg. 2000; 126: 940–946.
 
19a. Schilling A, Corey R, Leonard M, et al. Acetaminophen: old drug, new warnings. Cleve Clin J Med. 2010; 77: 19–27.
 
20. Meltzer EO, Charous BL, Busse WW, et al. Added relief in the treatment of acute recurrent sinusitis with adjunctive mometasone furoate nasal spray. The Nasonex Sinusitis Group. J Allergy Clin Immunol. 2000; 106: 630–637.
 
21. Dolor RJ, Witsell DL, Hellkamp AS, et al. Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. The CAFFS Trial: a randomized controlled trial. JAMA. 2001; 286: 3097–3105.
 
22. de Ferranti SD, Ioannidis JP, Lau J, et al. Are amoxicillin and folate inhibitors as effective as other antibiotics for acute sinusitis? A meta-analysis. BMJ. 1998; 317: 632–637.
 
23. Ip S, Fu L, Balk E, et al. Update on Acute Bacterial Rhinosinusitis. Evidence Report/Technology Assessment No. 124. AHRQ Publication No. 05-E020-2. Rockville, MD: Agency for Healthcare Research and Quality; 2005; .
 
24. Williams JW Jr, Aguilar C, Cornell J, et al. Antibiotics for acute maxillary sinusitis. Cochrane Database Syst Rev. 2003; 2: CD000243
 
25. Lindbaek M, Hjortdahl P, Johnsen UL. Randomised, double blind, placebo controlled trial of penicillin V and amoxicillin in treatment of acute sinus infections in adults. BMJ. 1996; 313: 325–329.
 
26. Lindbaek M, Kaastad E, Dolvik S, et al. Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut-off points in sinus CT. Rhinology. 1998; 36: 7–11.
 
27. Merenstein D, Whittaker C, Chadwell T, et al. Are antibiotics beneficial for patients with sinusitis complaints? A randomized double-blind clinical trial. J Fam Pract. 2005; 54: 144–151.
 
28. Roos K, Tellier G, Baz M, et al. Clinical and bacteriological efficacy of 5-day telithromycin in acute maxillary sinusitis: a pooled analysis. J Infect. 2005; 50: 210–220.
 
29. Ah-see K. Sinusitis (acute). Clin Evid. 2006; 15: 1–11.
 
30. Ioannidis JP, Chew P, Lau J. Standardized retrieval of side effects data for meta-analysis of safety outcomes: a feasibility study in acute sinusitis. J Clin Epidemiol. 2002; 55: 619–626.
 
31. DelGuadio JM, Evan SH, Sobol SE, et al. Intracranial complications of sinusitis: what is the role of endoscopic sinus surgery in the acute setting. Am J Otolaryngol. 2010; 31: 25–28.